We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+2.31%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$222M
AUM Growth
-$20.6M
(-8.5%)
Cap. Flow
-$25.2M
Cap. Flow
% of AUM
-11.33%
Top 10 Holdings %
Top 10 Hldgs %
79.28%
Holding
47
New
3
Increased
16
Reduced
12
Closed
10
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$6.04M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.53M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$1.43M |
| 4 |
Invesco Senior Loan ETF
BKLN
|
+$1.17M |
| 5 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ImmunityBio
IBRX
|
+$26.5M |
| 2 |
Vanguard Total Bond Market
BND
|
+$6.18M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$719K |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$638K |
| 5 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
+$494K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 100% |
| 2 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $56.4M | 25.4% |
2,835,005
+53,790
| +2% | +$1.03M |
2013 Q2
14 quarters
|
|
|
2
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $47.4M | 21.33% |
1,072,741
+34,413
| +3% | +$1.53M |
2013 Q2
14 quarters
|
|
3
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.3B
| $15M | 6.74% |
337,585
+117
| +0% | +$5.11K |
2015 Q4
4 quarters
|
|
4
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $12.9M | 5.81% |
534,084
+416
| +0.1% | +$9.93K |
2013 Q2
14 quarters
|
|
5
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $10.5M | 4.73% |
132,282
+2,225
| +2% | +$178K |
2014 Q4
8 quarters
|
|
6
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $7.68M | 3.46% |
111,406
+344
| +0.3% | +$23.9K |
2013 Q2
14 quarters
|
|
7
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $7.04M | 3.17% |
173,002
+444
| +0.3% | +$17.9K |
2013 Q2
14 quarters
|
|
8
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $6.88M | 3.1% |
296,018
-6,576
| -2% | -$141K |
2013 Q2
14 quarters
|
|
9
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.65B
| $6.33M | 2.85% |
274,630
+140
| +0.1% | +$3.06K |
2013 Q2
14 quarters
|
|
|
10
Vanguard Short-Term Bond ETF
BSV
$45.5B
| $6M | 2.7% |
+75,546
| New | +$6.04M |
2016 Q4
0 quarters
|
|
11
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $6M | 2.7% |
96,434
-232
| -0.2% | -$14K |
2013 Q2
14 quarters
|
|
12
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $5.92M | 2.67% |
179,964
+1,612
| +0.9% | +$52.2K |
2013 Q2
14 quarters
|
|
13
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.5B
| $5.27M | 2.37% |
101,890
+2,961
| +3% | +$153K |
2013 Q2
14 quarters
|
|
14
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $4.08M | 1.83% |
108,212
-1,398
| -1% | -$50.6K |
2013 Q2
14 quarters
|
|
|
15
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
| $3.49M | 1.57% |
135,606
-24,412
| -15% | -$638K |
2015 Q3
5 quarters
|
|
16
Schwab US Broad Market ETF
SCHB
$44.9B
| $1.92M | 0.87% |
213,078
-1,296
| -0.6% | -$11.4K |
2015 Q3
5 quarters
|
|
17
Schwab Fundamental US Broad Market Index ETF
FNDB
$1.5B
| $1.86M | 0.84% |
171,249
+14,661
| +9% | +$154K |
2016 Q2
2 quarters
|
|
18
iShares US Financials ETF
IYF
$3.84B
| $1.78M | 0.8% |
35,092
| – | – |
2013 Q2
14 quarters
|
|
19
State Street Materials Select Sector SPDR ETF
XLB
$7.99B
| $1.72M | 0.78% |
69,328
-1,330
| -2% | -$32.3K |
2013 Q2
14 quarters
|
|
20
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $1.67M | 0.75% |
68,772
+4,040
| +6% | +$96.5K |
2013 Q2
14 quarters
|
|
21
Alerian MLP ETF
AMLP
$12.5B
| $1.59M | 0.71% |
25,210
+6,711
| +36% | +$415K |
2015 Q4
4 quarters
|
|
|
22
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.6B
| $1.43M | 0.64% |
+14,142
| New | +$1.43M |
2016 Q4
0 quarters
|
|
23
iShares Europe ETF
IEV
$1.6B
| $1.27M | 0.57% |
32,730
-12,266
| -27% | -$468K |
2013 Q2
14 quarters
|
|
|
24
Invesco Senior Loan ETF
BKLN
$6.28B
| $1.18M | 0.53% |
+50,358
| New | +$1.17M |
2016 Q4
0 quarters
|
|
25
Schwab International Equity ETF
SCHF
$67B
| $1.05M | 0.47% |
75,728
+468
| +0.6% | +$6.56K |
2015 Q3
5 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Callan Capital held 47 positions worth $222M, down 8.5% from $243M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Callan Capital withdrew a net $25.2M in Q4 2016, closing 10 positions and reducing 12 holdings. Its most notable exit was ImmunityBio, an estimated $26.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 89% a quarter earlier, followed by Healthcare.
Against the trend, Callan Capital opened a new position in Vanguard Short-Term Bond ETF worth $6M.
- Callan Capital's largest Q4 2016 buy was Vanguard Short-Term Bond ETF: 75,546 shares worth $6M.
- Callan Capital added most to Vanguard FTSE All-World ex-US ETF in Q4 2016, an estimated $1.53M increase.
- Callan Capital's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $719K.
- Callan Capital fully exited ImmunityBio in Q4 2016, selling an estimated $26.5M.
- Callan Capital's ten largest holdings make up 79% of its $222M portfolio in Q4 2016.
- Callan Capital opened 3 new positions and closed 10 in Q4 2016.
- Callan Capital's portfolio value fell 8.5% quarter-over-quarter to $222M.
Based on Callan Capital's 13F filing for Q4 2016, filed 9 Feb 2017.